Corcept Therapeutics Announces Fourth Quarter and Full Year 2014 Revenue ...
Corcept Therapeutics Incorporated ( NASDAQ : CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, oncologic and psychiatric disorders, today reported its revenue for ...
Marketwired (press release) - Thu, 29 Jan 2015 13:00

Corcept Therapeutics Incorporated: Corcept Therapeutics Announces Fourth ...
Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, oncologic and psychiatric disorders, today reported its revenue for ...
The Wall Street Transcript - Thu, 29 Jan 2015 13:00

Brain control of liver lipid production may lead to new treatment for obesity ...
The study, conducted by Jessica Yue, of the Department of Physiology in the Faculty of Medicine and Dentistry, found a link between the brain's regulation of fat metabolism and the development of atherosclerosis, a condition in which the arteries ...
Diabetes.co.uk - Fri, 30 Jan 2015 06:37

Obesity and diabetes symptoms in mice improved by reversing brain inflammation
Dr Tups and an international team investigated whether directly stopping inflammatory processes in the brain's hypothalamus could help lower blood sugar levels and reduce insulin resistance. In their research the team ... To confirm that activation of ...
Medical Xpress - Thu, 29 Jan 2015 06:15

Public Release: 28-Jan-2015 Obesity and diabetes symptoms in mice improved ...
EurekAlert (press release) - Thu, 29 Jan 2015 06:15



ZS Pharma:: A Few Months Behind, But An Inpatient Advantage
ZS Pharma is a biopharmaceutical company with a focus on the development and commercialization of highly selective, non-absorbed polymer medications for the treatment of renal, cardiovascular, and metabolic disorders. The company's sole drug in ...
Seeking Alpha (registration) - Wed, 28 Jan 2015 06:48

Dementia in 2014: Towards early diagnosis in Alzheimer disease
... further studies will provide answers regarding spatial tau deposition in AD at different stages of the disease; for example, how does tau accumulation correspond to changes in cognition and CSF biomarkers, and to regional changes in glucose ...
Nature.com - Tue, 27 Jan 2015 02:13



University of Alberta Faculty of Medicine & Dentistry
Jessica Yue, a newly recruited researcher in the Department of Physiology in the Faculty of Medicine & Dentistry, has shown a link between how the brain can regulate fat metabolism, potentially stopping the development of this disease risk factor in ...
EurekAlert (press release) - Tue, 27 Jan 2015 08:30



Zero Belly, Zero Excuses
Once those genes get turned on, visceral fat acts like an invading force, trying to take over our bodies. Some of us carry a number of genes linked to metabolic disorders like diabetes and obesity; others have a lower genetic propensity for these ...
Men's Fitness - Tue, 27 Jan 2015 07:41


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014